Analytical and Clinical Validity Study of FirstStepDx PLUS: A Chromosomal Microarray Optimized for Patients with Neurodevelopmental Conditions

INTRODUCTION: Chromosomal microarray analysis (CMA) is recognized as the first-tier test in the genetic evaluation of children with developmental delays, intellectual disabilities, congenital anomalies and autism spectrum disorders of unknown etiology. ARRAY DESIGN: To optimize detection of clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hensel, Charles, Vanzo, Rena, Martin, Megan, Dixon, Sean, Lambert, Christophe, Levy, Brynn, Nelson, Lesa, Peiffer, Andy, Ho, Karen S., Rushton, Patricia, Serrano, Moises, South, Sarah, Ward, Kenneth, Wassman, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Evidence on Genomic Tests
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346028/
https://www.ncbi.nlm.nih.gov/pubmed/28357155
http://dx.doi.org/10.1371/currents.eogt.7d92ce775800ef3fbc72e3840fb1bc22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346028/
https://www.ncbi.nlm.nih.gov/pubmed/28357155
http://dx.doi.org/10.1371/currents.eogt.7d92ce775800ef3fbc72e3840fb1bc22

Ejemplares similares